alternatives to glp-1 drugs for weight loss agonist medications The Boom in New Weight Loss Drugs: What Prehospital Why Weight Loss Injections Don't

Cureus (2020) 12(11):e11703

Neuropsychopharmacology 35, 192216

The addition of AMPLITUDE-O data refined evidence for cardiovascular benefits, in particular showing reduction in hospital admission for heart failure, and suggested exendin-4-based compounds lower risks as well as human-based GLP-1 receptor agonists, Naveed Sattar, MD, PhD, professor of metabolic medicine at the University of Glasgow in the U.K., and colleagues wrote

Patient-reported outcomes data from clinical trials in Japanese patients indicated that patients considered less frequent injections more convenient and flexible (51) and that their use led to an improvement in quality of life, without compromising glycemic control (52)

Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells

Do GLP-1 patches actually work for weight loss